Phentermine and topiramate 11.25 mg/1

Active Ingredient:
Form:
Brand:
Origin:

Buy Phentermine and topiramate 11.25 mg/1

Phentermine and topiramate 11.25 mg/1 extended-release capsules are a combination medication used for weight management. This prescription-only treatment is designed to support weight loss efforts in conjunction with a reduced-calorie diet and increased physical activity.

Strength

11.25 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-2299-56)

Storage

Not specified

Manufacturer

Teva Pharmaceuticals, Inc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below with your details, and a member of our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Phentermine and topiramate 11.25 mg/1 is primarily used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition. This medication is intended for individuals with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one obesity-related condition such as high blood pressure, type 2 diabetes, or dyslipidemia. The combination of phentermine, an appetite suppressant, and topiramate, an anticonvulsant, works to reduce appetite and promote weight loss.

Side Effects

  • Common effects of phentermine and topiramate 11.25 mg/1 may include decreased appetite, increased energy levels, and weight loss. Some users may experience side effects such as dry mouth, constipation, dizziness, or changes in taste. It is important to note that individual responses to the medication can vary, and not everyone will experience the same effects.

Precautions & Warnings

  • Phentermine and topiramate 11.25 mg/1 should be used with caution and under the supervision of a healthcare provider. It is important to follow the prescribed dosage and not to exceed the recommended amount. This medication should not be used during pregnancy or while breastfeeding. Individuals with a history of heart disease, hyperthyroidism, glaucoma, or those taking certain medications should consult their healthcare provider before starting this treatment.

Avoid Interactions

  • Phentermine and topiramate 11.25 mg/1 may interact with other medications, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and other appetite suppressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be avoided while taking this medication, as it may increase the risk of side effects.

References

FAQ's

Phentermine and topiramate 11.25 mg/1 is used for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition.

Phentermine and topiramate 11.25 mg/1 should be taken orally, typically once daily in the morning, with or without food, as directed by a healthcare provider.

Common side effects may include dry mouth, constipation, dizziness, and changes in taste. Individual responses can vary.

Phentermine and topiramate 11.25 mg/1 should not be used during pregnancy. Consult a healthcare provider for personalized advice.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. It is not exhaustive and may not cover all medical conditions, treatments, or precautions. Always consult a qualified healthcare professional regarding any medical concerns. Do not ignore or delay seeking medical advice based on information provided here.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer / TM Owner" section in compliance with statutory requirements.

By continuing to access or use this website, you acknowledge and agree to the terms set forth herein. If you do not consent to these terms, you are advised to discontinue browsing immediately. Should you identify any inaccuracy, infringement, or other concern, you are encouraged to promptly report the matter for review and appropriate action. If you wish to request the removal of a product or any part of its content, please contact us at legal@gnhindia.com.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form illustration

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment confirmation

03

Confirm & Make Payment

Discuss any queries you may have, approve the estimate, and complete your payment.

Worldwide medicine delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence in pharmaceutical distribution.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001 Certification

URS ISO 9001 Certification

FDA Maharashtra License

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT